Search

Your search keyword '"Buhl, Timo"' showing total 117 results

Search Constraints

Start Over You searched for: Author "Buhl, Timo" Remove constraint Author: "Buhl, Timo" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
117 results on '"Buhl, Timo"'

Search Results

1. Symptom severity reflected by NYHA grade is independently associated with pruritus in chronic heart failure patients.

4. Epithelial–immune cell interactions in allergic diseases.

5. Ganzkörper‐Blaulichtbestrahlung zur Behandlung der atopischen Dermatitis: eine randomisierte, placebokontrollierte klinische Studie (AD‐Blue).

6. Full‐body blue light irradiation as treatment for atopic dermatitis: a randomized sham‐controlled clinical trial (AD‐Blue).

9. Aktuelle Situation der allergologischen Versorgung an deutschen Kliniken.

10. Current situation of allergological health care at German hospitals.

11. Patch testing hydroperoxides of limonene and linalool in consecutive patients—Results of the IVDK 2018–2020.

12. Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial.

13. Atopic dermatitis – Perspectives and unmet medical needs.

14. Atopische Dermatitis – Perspektiven und unerfüllte medizinische Bedarfe.

15. Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity.

16. Meeting Report: 47th Annual Meeting of the "Arbeitsgemeinschaft Dermatologische Forschung".

17. Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC.

20. The benefit of late readings in patch testing depends both on allergen and patient characteristics.

21. European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC.

22. Identification of novel biomarkers to distinguish bradykinin‐mediated angioedema from mast cell‐/histamine‐mediated angioedema.

25. Very late reactions in the patch test with fragrance mix I and oak moss absolute (Evernia prunastri, INCI): Data of the Information Network of Departments of Dermatology (IVDK).